Doug Killion

Mr. Killion is a seasoned industry executive with 28 years of serial medical device development, clinical evaluation and commercialization experience. He most recently served as President of Sealing Solutions Inc., where he led the company from inception in 2008 to its successful acquisition by St. Jude Medical in 2010. Preceding its acquisition, Sealing Solutions had developed an innovative vascular closure device capable of enabling a wide range of minimally invasive procedures. Prior to joining Sealing Solutions, he held a variety of cross-functional senior management positions at Boston Scientific including global marketing, business development, and program management. During his 13‑year tenure, Doug was responsible for leading four major new business initiatives within the company. Before joining Boston Scientific, he held various medical device engineering and project management positions at SciMed Life Systems.

Mr. Killion earned his MBA in Strategy and Marketing from the University of Minnesota Carlson School of Management, and holds a BS in Mechanical/Biomedical Engineering from the University of Minnesota.

Roy Martin Jr.

Mr. Martin has been CEO of WELM Ventures, a venture capital firm, since 2011. WELM invests in early stage companies in information technology, digital media and medical device industries. From 2013 to 2017, he also served as a senior executive of Truven Health Analytics, a $600 million (revenue) global healthcare analytics company, owned by private equity, which sold for $2.6 billion in 2016 to IBM Watson Health. Before that, for 18 years Roy was a senior executive and one of 5 division CEO’s at Thomson Reuters, leading global businesses in the legal and scientific markets. He was most recently the president & CEO of the 5,500 employee Thomson Reuters Tax & Accounting business, where he was credited with the company’s successful worldwide expansion, and its explosive growth from $450 million in revenue in 2004 to $1.2 billion in 2011.

Mr. Martin holds an MBA from Emory University and maintains an office in downtown Minneapolis, MN.

Bob Ziebol

Mr. Ziebol has over 25 years of R&D experience. He founded Ziebol & Associates in 1994 and Pursuit Medical in 2008 to help start-up companies develop medical device concepts into commercial products. Bob has successfully demonstrated his abilities in helping build nine companies, taking multiple products from idea to market, and leading diverse teams to successful product outcomes. He has extensive experience in dialysis-related technologies, holds over twenty issued US and foreign patents, and has several patents pending.

Mr. Ziebol holds BS degrees in both Engineering Physics and Electrical Engineering from South Dakota State University.

Keith Modert

Mr. Modert has more than 20 years of product development and manufacturing experience in the medical device industry. Prior to joining Pursuit Vascular, he was responsible for process development, validations, and manufacturing operations that contributed to PMA approval of the LINX device at Torax Medical. Before joining Torax Medical, Keith was an R&D Engineer at Mentor Urology and an R&D Manager and Mentor Urology and Coloplast. As an R&D Engineer, Keith provided technical and project leadership for two PMA approved products and two 510(k) cleared products. As an R&D Manager, he led a team of fifteen employees and managed annual budgets of $3-$4 million to launch six medical devices in three years, while successfully navigating integration into Coloplast.

Mr. Modert has a Bachelor of Chemical Engineering from the University of Minnesota Institute of Technology (now College of Science and Engineering).

Greg Walpole

Mr. Walpole is a seasoned sales executive in the medical device industry with over 20 years of experience in medical sales. He most recently led sales efforts for Ecomed Solutions, a privately held company in Chicago, Illinois. Prior to his time there, he successfully led sales for the renal division at ICU Medical, Inc. for nine years. He also held increasing levels of sales responsibility in home care and intravenous products earlier in his career.

Mr. Walpole received his bachelor's degree in Business Administration from the University of Texas at Dallas.

Laurie Lynch, PhD

Dr. Lynch has over 23 years of medical device experience in startup companies in the areas of Product Development, Clinical, Regulatory, Manufacturing and Quality Assurance. As General Manager of Hemosphere (acquired by CryoLife), she was responsible for the successful development and commercialization of the HeRO Vascular Access Device for hemodialysis. In this role she was responsible for all FDA submissions, clinical testing, and created and maintained all quality system functions. Before joining Hemosphere, she was with Advanced Bio-Surfaces where she was lead the operations that were used to sterilize knee and spine device polymers. Prior to Advanced Bio‑Surfaces, Laurie held various positions at Optical Sensors, with primary responsibility for an extracorporeal blood gas sensing device that was commercialized in the U.S.

Dr. Lynch holds a BS in Chemistry from Canisius College, and a Ph.D. in Organic Chemistry from the University of Minnesota.

Renee Koziol

Ms. Koziol has over 25 years of experience in multiple areas of medical device, health care and disease management industries. She has a strong track record of success across a broad spectrum of marketing of new products and technologies. Her experience includes expertise in product management, sales and client services, market research, and health economics in numerous Fortune 500 companies, including Medtronic, St. Jude Medical and Optum, as well as a variety of start-up and growth companies.

Ms. Koziol received her MBA from the University of St. Thomas in St. Paul, MN and obtained her bachelor's degree in nursing from the St. Catherine University in St. Paul, MN.